Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Lonza Group    LONN   CH0013841017

LONZA GROUP (LONN)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
12/04/2018 12/05/2018 12/06/2018 12/07/2018 12/10/2018 Date
328.6(c) 324.5(c) 308.1(c) 307.6(c) 299.3 Last
275 070 233 765 446 876 276 395 338 954 Volume
-0.12% -1.25% -5.05% -0.16% -2.70% Change
More quotes
Financials (CHF)
Sales 2018 6 083 M
EBIT 2018 1 166 M
Net income 2018 761 M
Debt 2018 3 552 M
Yield 2018 1,07%
Sales 2019 6 418 M
EBIT 2019 1 313 M
Net income 2019 892 M
Debt 2019 3 089 M
Yield 2019 1,20%
P/E ratio 2018 29,78
P/E ratio 2019 24,07
EV / Sales2018 4,35x
EV / Sales2019 4,05x
Capitalization 22 907 M
More Financials
Company
Lonza Group is one of the world leaders of the development, production and marketing of chemical products. Net sales break down by family of products and services as follows: - fine organic and performance chemical products (54.9%): for food products, hygiene products, beauty products, water... 
More about the company
Surperformance© ratings of Lonza Group
Trading Rating : Investor Rating :
More Ratings
Latest news on LONZA GROUP
09:45aLONZA : to Establish Biomanufacturing Base in China
DJ
07:05aLonza to Establish Strategic Biomanufacturing Base in China Using GE Healthca..
TE
12/06LONZA : Consumer Health and Nutrition Granted U.S. Patent for L-Carnitine in Ani..
AQ
12/05LONZA : Consumer Health and Nutrition Granted U.S. Patent for L-Carnitine (Carni..
PU
11/21LONZA : Brings Extended Portfolio of Colored Clean Label Capsules to Hi Europe
PU
11/19LONZA : Opens Collaborative Innovation Center in Haifa, Israel
PU
11/17LONZA : RIBUS Unveils Clean Label Alliance Along with BIOGRUND, Bosch, Lonza And..
AQ
11/15Lonza and Sartorius Stedim Biotech Modify Relationship for Supply of Cell Cul..
TE
11/15LONZA : Water Care France to Be Included in the Transition to Platinum Equity
AQ
11/15LONZA : Global Subject Matter Expert for Endotoxin Detection Appointed Chair of ..
AQ
More news
Stock Trading Strategies
LONZA GROUP - 04/20
Technically solid
BUY
More Stock Trading Analysis
Sector news : Biotechnology & Medical Research - NEC
08:56aRoche Pharmaceuticals Names New CEO as O'Day Leaves to Head Gilead -- Update
DJ
08:53aRoche Executive Named Gilead CEO -- 2nd Update
DJ
08:48aGilead Taps Roche Veteran as New CEO -- WSJ
DJ
07:53aROCHE : Gilead Sciences snares Roche executive O'Day as CEO
RE
03:26aRoche Executive to Be Named Gilead CEO -- Update
DJ
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
09:45aLonza : to Establish Biomanufacturing Base in China  
12/05Lonza : Consumer Health and Nutrition Granted U.S. Patent for L-Carnitine (Ca.. 
11/26Lonza opens new research center in Israel: Switzerland-based Lonza, a leader .. 
11/21Lonza : Brings Extended Portfolio of Colored Clean Label Capsules to Hi Europ.. 
11/09Cyanate Ester Resin Market to 2023: Market is Expected to Grow at a CAGR of 5.. 
More tweets
Qtime:28
News from SeekingAlpha
10/25Lonza Group AG (LZAGY) CEO Richard Ridinger on Q3 2018 Results - Earnings Cal.. 
10/25Lonza Group AG ADR 2018 Q3 - Results - Earnings Call Slides 
07/30Lonza Group AG ADR's (LZAGY) CEO Richard Ridinger on Q2 2018 Results - Earnin.. 
07/25Lonza Group AG ADR 2018 Q2 - Results - Earnings Call Slides 
07/25Lonza Group AG reports 1H results 
Chart LONZA GROUP
Duration : Period :
Lonza Group Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LONZA GROUP
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 361  CHF
Spread / Average Target 17%
EPS Revisions
Managers
NameTitle
Richard Ridinger Chief Executive Officer
Albert M. Baehny Chairman
Rodolfo Savitzky Chief Financial Officer
Patrick Aebischer Vice Chairman
Margot A. Scheltema Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
LONZA GROUP16.82%23 110
CELLTRION, INC.--.--%27 412
IQVIA HOLDINGS INC20.51%23 601
INCYTE CORPORATION-31.89%13 728
SEATTLE GENETICS, INC.12.13%9 680
EXACT SCIENCES CORPORATION36.47%8 812